Nature Communications · 2024 · 43 citations · 70 references
MedicineOncologyPharmacologyCancer ImmunologyCancer PharmacologyChemotherapyAntitumor T Cell ResponsesCancer ImmunotherapyTargeted Cancer TherapyTargeted TherapyTumor Microenvironment ModulationCancer Cell Proliferation InhibitionCancer NanotherapyCd44 TargetingNanoparticle-based ChemotherapyTherapeutic Resistance MechanismsTumor Immune Cell InfiltrationTumor Targeting LigandsTumor Vasculature Targeting
The multifaceted chemo-immune resistance is the principal barrier to achieving cure in cancer patients. Identifying a target that is critically involved in chemo-immune-resistance represents an attractive strategy to improve cancer treatment. iRhom1 plays a role in cancer cell proliferation and its expression is negatively correlated with immune cell infiltration. Here we show that iRhom1 decreases chemotherapy sensitivity by regulating the MAPK14-HSP27 axis. In addition, iRhom1 inhibits the cytotoxic T-cell response by reducing the stability of ERAP1 protein and the ERAP1-mediated antigen processing and presentation. To facilitate the therapeutic translation of these findings, we develop a biodegradable nanocarrier that is effective in codelivery of iRhom pre-siRNA (pre-siiRhom) and chemotherapeutic drugs. This nanocarrier is effective in tumor targeting and penetration through both enhanced permeability and retention effect and CD44-mediated transcytosis in tumor endothelial cells as well as tumor cells. Inhibition of iRhom1 further facilitates tumor targeting and uptake through inhibition of CD44 cleavage. Co-delivery of pre-siiRhom and a chemotherapy agent leads to enhanced antitumor efficacy and activated tumor immune microenvironment in multiple cancer models in female mice. Targeting iRhom1 together with chemotherapy could represent a strategy to overcome chemo-immune resistance in cancer treatment.
70
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
Zefang Tang, Boxi Kang, Chenwei Li et al. · Nucleic Acids Research · 2019 · 5.4K citations · Full text
Architecture of the human interactome defines protein communities and disease networks
Edward L. Huttlin, Raphael J. Bruckner, João A. Paulo et al. · Nature · 2017 · 1.6K citations · Full text